Bellevue Group’s Edgewise Therapeutics EWTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$36.4M Buy
2,775,997
+1,347,068
+94% +$17.7M 0.8% 33
2025
Q1
$31.4M Hold
1,428,929
0.7% 35
2024
Q4
$38.2M Hold
1,428,929
0.73% 29
2024
Q3
$38.1M Hold
1,428,929
0.62% 46
2024
Q2
$25.7M Buy
+1,428,929
New +$25.7M 0.42% 62